Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Pterocarya fraxinifolia
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Pterocarya fraxinifolia exerts its effects primarily through its high tannin content. Tannins act as astringents by precipitating proteins in the skin and mucous membranes, which creates a protective layer that reduces inflammation, irritation, and secretion. This mechanism supports its traditional use for treating skin conditions. Trace amounts of juglone may also contribute antimicrobial properties, though specific clinical trials are limited (Evidence Level C).
No, Pterocarya fraxinifolia is considered unsafe during pregnancy and breastfeeding. The herb contains juglone and significant levels of tannins, which may stimulate uterine contractions or interfere with nutrient absorption. Traditional astringent remedies are generally contraindicated for pregnant women. Women who are pregnant or nursing should avoid this herb entirely (Evidence Level C).
The traditional adult dosage for Pterocarya fraxinifolia is approximately 2 grams of dried bark, typically prepared as a tea or decoction. This dosage is based on ethnobotanical use for skin conditions and astringent effects. Because modern pharmacological studies are limited, users should adhere strictly to traditional preparation guidelines and consult a medical professional before use (Evidence Level C).
Due to its high tannin content, Pterocarya fraxinifolia may interfere with the absorption of certain oral medications and iron supplements. Tannins can bind to alkaloids and minerals in the digestive tract, potentially reducing their bioavailability and efficacy. It is advisable to separate the consumption of this herb from prescription medications by at least two hours (Evidence Level D).
Reported side effects are generally mild and may include gastrointestinal upset or skin irritation in sensitive individuals. A significant safety concern involves potential cross-reactions in individuals with nut allergies, specifically those allergic to the Juglandaceae family (walnuts and hickories). Users should discontinue use immediately if allergic symptoms such as itching or swelling occur (Evidence Level D).
In traditional folk medicine, Pterocarya fraxinifolia is primarily used for treating skin conditions and as a natural astringent. The bark is applied to help manage minor wounds, inflammation, and excessive secretions. While it has a history of use in Caucasian riparian regions, modern scientific validation for these specific applications remains limited (Evidence Level C).
Cette plante ne dispose pas d'une monographie rédigée par un humain, et le contenu généré par IA n'est pas affiché ici. Consultez les sources gouvernementales et les études primaires PubMed (NIH) listées ci-dessous pour des informations fiables. Confirmez toujours auprès d'un professionnel de santé avant utilisation.
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.